Cargando…

Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers

BACKGROUND: Fiducial markers and daily electronic portal imaging (EPI) can reduce the risk of geographic miss in prostate cancer radiotherapy. The purpose of this study was to estimate CTV to PTV margin requirements, without and with the use of this image guidance strategy. METHODS: 46 patients unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Skarsgard, David, Cadman, Pat, El-Gayed, Ali, Pearcey, Robert, Tai, Patricia, Pervez, Nadeem, Wu, Jackson
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896366/
https://www.ncbi.nlm.nih.gov/pubmed/20537161
http://dx.doi.org/10.1186/1748-717X-5-52
_version_ 1782183343563997184
author Skarsgard, David
Cadman, Pat
El-Gayed, Ali
Pearcey, Robert
Tai, Patricia
Pervez, Nadeem
Wu, Jackson
author_facet Skarsgard, David
Cadman, Pat
El-Gayed, Ali
Pearcey, Robert
Tai, Patricia
Pervez, Nadeem
Wu, Jackson
author_sort Skarsgard, David
collection PubMed
description BACKGROUND: Fiducial markers and daily electronic portal imaging (EPI) can reduce the risk of geographic miss in prostate cancer radiotherapy. The purpose of this study was to estimate CTV to PTV margin requirements, without and with the use of this image guidance strategy. METHODS: 46 patients underwent placement of 3 radio-opaque fiducial markers prior to prostate RT. Daily pre-treatment EPIs were taken, and isocenter placement errors were corrected if they were ≥ 3 mm along the left-right or superior-inferior axes, and/or ≥ 2 mm along the anterior-posterior axis. During-treatment EPIs were then obtained to estimate intra-fraction motion. RESULTS: Without image guidance, margins of 0.57 cm, 0.79 cm and 0.77 cm, along the left-right, superior-inferior and anterior-posterior axes respectively, are required to give 95% probability of complete CTV coverage each day. With the above image guidance strategy, these margins can be reduced to 0.36 cm, 0.37 cm and 0.37 cm respectively. Correction of all isocenter placement errors, regardless of size, would permit minimal additional reduction in margins. CONCLUSIONS: Image guidance, using implanted fiducial markers and daily EPI, permits the use of narrower PTV margins without compromising coverage of the target, in the radiotherapy of prostate cancer.
format Text
id pubmed-2896366
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28963662010-07-03 Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers Skarsgard, David Cadman, Pat El-Gayed, Ali Pearcey, Robert Tai, Patricia Pervez, Nadeem Wu, Jackson Radiat Oncol Research BACKGROUND: Fiducial markers and daily electronic portal imaging (EPI) can reduce the risk of geographic miss in prostate cancer radiotherapy. The purpose of this study was to estimate CTV to PTV margin requirements, without and with the use of this image guidance strategy. METHODS: 46 patients underwent placement of 3 radio-opaque fiducial markers prior to prostate RT. Daily pre-treatment EPIs were taken, and isocenter placement errors were corrected if they were ≥ 3 mm along the left-right or superior-inferior axes, and/or ≥ 2 mm along the anterior-posterior axis. During-treatment EPIs were then obtained to estimate intra-fraction motion. RESULTS: Without image guidance, margins of 0.57 cm, 0.79 cm and 0.77 cm, along the left-right, superior-inferior and anterior-posterior axes respectively, are required to give 95% probability of complete CTV coverage each day. With the above image guidance strategy, these margins can be reduced to 0.36 cm, 0.37 cm and 0.37 cm respectively. Correction of all isocenter placement errors, regardless of size, would permit minimal additional reduction in margins. CONCLUSIONS: Image guidance, using implanted fiducial markers and daily EPI, permits the use of narrower PTV margins without compromising coverage of the target, in the radiotherapy of prostate cancer. BioMed Central 2010-06-10 /pmc/articles/PMC2896366/ /pubmed/20537161 http://dx.doi.org/10.1186/1748-717X-5-52 Text en Copyright ©2010 Skarsgard et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Skarsgard, David
Cadman, Pat
El-Gayed, Ali
Pearcey, Robert
Tai, Patricia
Pervez, Nadeem
Wu, Jackson
Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
title Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
title_full Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
title_fullStr Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
title_full_unstemmed Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
title_short Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
title_sort planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896366/
https://www.ncbi.nlm.nih.gov/pubmed/20537161
http://dx.doi.org/10.1186/1748-717X-5-52
work_keys_str_mv AT skarsgarddavid planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers
AT cadmanpat planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers
AT elgayedali planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers
AT pearceyrobert planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers
AT taipatricia planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers
AT perveznadeem planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers
AT wujackson planningtargetvolumemarginsforprostateradiotherapyusingdailyelectronicportalimagingandimplantedfiducialmarkers